171 related articles for article (PubMed ID: 32994701)
41. Nomogram Predicts the Role of Primary Tumor Surgery on
Cui H; Dai L; Bao Y; Hu L; Zhou Z; Wang M; Lin S; Wu H; Ma X; Kang H
Front Oncol; 2022; 12():819531. PubMed ID: 35600374
[TBL] [Abstract][Full Text] [Related]
42. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
[TBL] [Abstract][Full Text] [Related]
43. Readdressing the Role of Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer.
Khan SA; DesJardin ESM
Cancer Treat Res; 2018; 173():73-88. PubMed ID: 29349759
[TBL] [Abstract][Full Text] [Related]
44. Operative Management in Stage IV Breast Cancer.
Vemuru SR; Tevis SE
Surg Clin North Am; 2023 Feb; 103(1):93-106. PubMed ID: 36410356
[TBL] [Abstract][Full Text] [Related]
45. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis.
Kim KN; Qureshi MM; Huang D; Ko NY; Cassidy M; Oshry L; Hirsch AE
Clin Breast Cancer; 2020 Apr; 20(2):e200-e213. PubMed ID: 32089454
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of primary disease with irradiation in case of de novo metastatic breast cancer].
Ghannam Y; Bourgier C; Legouté F; Gonzalez-Moya A; Lizée T; Trémolières P; Hennequin C
Cancer Radiother; 2020 Oct; 24(6-7):567-575. PubMed ID: 32814669
[TBL] [Abstract][Full Text] [Related]
47. Impact of Locoregional Treatment on Prognosis of de novo Stage IV Breast Cancer: A Retrospective Long-Term Study of Chinese Population.
Wang W; Liu J; Wang J; Gao J; Wang X; Wang X
Gynecol Obstet Invest; 2019; 84(3):248-258. PubMed ID: 30448829
[TBL] [Abstract][Full Text] [Related]
48. Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer.
Huang Z; Tan Q; Qin Q; Mo Q; Wei C
Cancer Manag Res; 2021; 13():319-327. PubMed ID: 33469374
[TBL] [Abstract][Full Text] [Related]
49. Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer.
Chen PY; Cheng SH; Hung CF; Yu BL; Chen CM
Springerplus; 2013; 2():589. PubMed ID: 25674416
[TBL] [Abstract][Full Text] [Related]
50. Comparison of outcomes between women with de novo stage IV and relapsed breast cancer.
Kitagawa D; Horiguchi S; Yamashita T; Kuroi K; Shimizu K
J Nippon Med Sch; 2014; 81(3):139-47. PubMed ID: 24998960
[TBL] [Abstract][Full Text] [Related]
51. Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
Lane WO; Thomas SM; Blitzblau RC; Plichta JK; Rosenberger LH; Fayanju OM; Hyslop T; Hwang ES; Greenup RA
Ann Surg; 2019 Mar; 269(3):537-544. PubMed ID: 29227346
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of primary tumor surgery in
Yang YS; Chen YL; Di GH; Jiang YZ; Shao ZM
Transl Cancer Res; 2019 Apr; 8(2):614-625. PubMed ID: 35116794
[TBL] [Abstract][Full Text] [Related]
53. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Rivera S; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; De La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Courtinard C; Filleron T; Robain M; Dalenc F
Radiother Oncol; 2020 Apr; 145():109-116. PubMed ID: 31931289
[TBL] [Abstract][Full Text] [Related]
54. A nomogram for predicting brain metastasis in patients with de novo stage IV breast cancer.
Sun MS; Liu YH; Ye JM; Liu Q; Cheng YJ; Xin L; Xu L
Ann Transl Med; 2021 May; 9(10):853. PubMed ID: 34164487
[TBL] [Abstract][Full Text] [Related]
55. A debate on locoregional treatment of the primary tumor in patients presenting with stage IV breast cancer.
Nguyen DH; Truong PT
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1913-22. PubMed ID: 22117158
[TBL] [Abstract][Full Text] [Related]
56. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.
Badwe R; Hawaldar R; Nair N; Kaushik R; Parmar V; Siddique S; Budrukkar A; Mittra I; Gupta S
Lancet Oncol; 2015 Oct; 16(13):1380-8. PubMed ID: 26363985
[TBL] [Abstract][Full Text] [Related]
57. Should breast surgery be considered for patients with de novo metastatic inflammatory breast cancer?
Drapalik LM; Shenk R; Rock L; Simpson A; Amin AL; Miller ME
Am J Surg; 2024 Jul; 233():52-60. PubMed ID: 38458830
[TBL] [Abstract][Full Text] [Related]
58. Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.
Bjelic-Radisic V; Fitzal F; Knauer M; Steger G; Egle D; Greil R; Schrenk P; Balic M; Singer C; Exner R; Soelkner L; Gnant M;
BMC Cancer; 2020 May; 20(1):392. PubMed ID: 32375735
[TBL] [Abstract][Full Text] [Related]
59. Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer.
Su CC; Wu JT; Choi E; Myall NJ; Neal JW; Kurian AW; Stehr H; Wood D; Henry SM; Backhus LM; Leung AN; Wakelee HA; Han SS
JAMA Netw Open; 2023 Sep; 6(9):e2335813. PubMed ID: 37751203
[TBL] [Abstract][Full Text] [Related]
60. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.
Le Scodan R; Stevens D; Brain E; Floiras JL; Cohen-Solal C; De La Lande B; Tubiana-Hulin M; Yacoub S; Gutierrez M; Ali D; Gardner M; Moisson P; Villette S; Lerebours F; Munck JN; Labib A
J Clin Oncol; 2009 Mar; 27(9):1375-81. PubMed ID: 19204198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
